Peter Lamprecht

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. Charles Jennette, Ronald J. Falk, P. A. Bacon et al. · Arthritis & Rheumatism · 2012 · 6.4K citations · Full text

K. Takahashi, Vasculitis, Immunology +19

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

Cem Gabay, Bruno Fautrel, Jürgen Rech et al. · Annals of the Rheumatic Diseases · 2018 · 284 citations · Full text

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Paul Lyons, James E. Peters, Federico Alberici et al. · Nature Communications · 2019 · 258 citations · Full text

Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

Peter Lamprecht · British journal of rheumatology · 2002 · 247 citations

Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis

András Komócsi, Peter Lamprecht, Elena Csernok et al. · American Journal Of Pathology · 2002 · 204 citations · Full text

Immunodeficiencies, Wegener ’, Immune Regulation +16